Leading Cardiovascular Researchers Present Promising Bendavia Findings at ... EON: Enhanced Online News (press release) Stealth is a privately held biopharmaceutical company developing innovative mitochondrial therapies for diseases with unmet medical needs including heart failure and chronic kidney disease. Bendavia is a novel compound that targets mitochondria ... |
